BRITTANY THOMAS

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology ATLANTA, GA NPI 1194969733

General Payments — all program years on this page

$1,029.04

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 39
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $132.18 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $81.193
Education $50.999

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Retrophin, Inc. $50.999
Edwards Lifesciences Corporation $37.521
Daiichi Sankyo Inc. $25.541
LeMaitre Vascular, Inc. $18.131

By program year

Program yearAmountRecords
2018 $263.2610
2019 $403.269
2020 $191.036
2021 $19.691
2023 $19.621
2024 $132.1812

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089490438 Daiichi Sankyo Inc. $25.54 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138054403 LeMaitre Vascular, Inc. $18.13 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138835578 Edwards Lifesciences Corporation $37.52 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149891390 Travere Therapeutics, Inc. $0.37 06/15/2024 Education Undisputed 01/23/2026 View at CMS
1149891394 Travere Therapeutics, Inc. $0.37 09/17/2024 Education Undisputed 01/23/2026 View at CMS
1149891398 Travere Therapeutics, Inc. $3.08 02/01/2024 Education Undisputed 01/23/2026 View at CMS
1149891402 Travere Therapeutics, Inc. $3.08 06/15/2024 Education Undisputed 01/23/2026 View at CMS
1149891406 Travere Therapeutics, Inc. $3.08 08/01/2024 Education Undisputed 01/23/2026 View at CMS
1149891410 Travere Therapeutics, Inc. $3.08 09/17/2024 Education Undisputed 01/23/2026 View at CMS
1149891414 Travere Therapeutics, Inc. $4.15 09/17/2024 Education Undisputed 01/23/2026 View at CMS
1149891418 Travere Therapeutics, Inc. $16.89 02/01/2024 Education Undisputed 01/23/2026 View at CMS
1149891422 Travere Therapeutics, Inc. $16.89 08/01/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.